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THE THERAPEUTIC EFFECT OF SULFADIAZINE AND
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WILLIAM L. BRADFORD, ANNE M. BROOKS, AND CHRIS P. KATSAMPES
Although certain members of the sulfonamide group of drugs
have been used in the treatment of the complications of whooping
cough,4' 5' 7, 8, 9, 12, 13 but little attention has been given to their effect
on the specific organism, Hemophilus pertwssis. Previous work"'
has failed to show a favorable influence of sulfanilamide and sulfa-
pyridine on the course of experimental pertussis in the mouse. A
recent report by Hornibrook' indicates that sulfadiazine is definitely
effective on the course of experimental infection produced by H. per-
tussis in the rat. Hornibrook's report and our own studies on
immune rabbit serums led us to investigate the effect of sulfadiazine
alone and in combination with serum in experimental pertussis.
Method and materials
Three-week-old Swiss mice, of uniform size, were infected while under
light ether anesthesia by dropping varying dilutions of a standardized suspen-
sion of H. pertussis into the nares. The suspension of organisms was prepared
by washing the 72-hour growth of H. pertussis from the surface of Bordet's
medium into 0.85 per cent sodium chloride solution. It was diluted to con-
tain approximately 10 billion organisms per milliliter. The mice were
separated into 5 subgroups of 6 mice each, and the infecting doses for the
subgroups were 250, 62.5, 15.6, 3.9, and 0.97 million organisms, respectively.
Since these experiments were designed to test the therapeutic effect,
administration of the drug and of the serums was made 24 hours after
the inoculation of the mice. The sulfadiazine in 0.5 per cent solution was
injected intra-abdominally twice daily in amounts such that the total daily
dose was 0.1 gm. per kg. of body weight. The injections were continued for
7 days.
Two immune rabbit serums were tested: an immune rabbit globulin,
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Rochester School of Medicine and Dentistry. This work was aided in part by
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and an antitoxin.* The immune rabbit globulin was precipitated from
immune serum prepared by immunizing rabbits by the intravenous injec-
tion of suspensions of killed, freshly isolated H. pertussis. This globulin
fraction possessed a high agglutinating titer, protected mice against fatal
doses of H. pertussis, but did not neutralize H. pertussis toxin. The antitoxin
was prepared by injecting rabbits with H. pertussis toxin. After purification,
it possessed a low agglutinating titer against H. pertussis, protected mice
against the experimental disease, and in high dilutions it neutralized H. per-
tussis toxin. In each instance, the dose of serum was 0.2 ml. of a 1:10
dilution, injected intra-abdominally 24 hours after infection of the mouse.
Daily injections were continued for a period of 7 days.
The mice were observed for 10 days, during which period the mortality
rate of each group was determined. Surviving mice were killed at the end
of the 10-day period, at which time cultures were made from the lungs.
The criteria employed to measure the therapeutic effectiveness of the agents
tested were: (a) mortality rate; (b) the clearance of the organisms from
the lungs of the surviving mice. By using the fifty per cent end-point
method described by Reed and Muench,10 the minimal lethal dose (M.L.D.)
for each group of 30 mice was calculated.
Results
The data (Table 1) illustrate the therapeutic effect of sulfa-
diazine as tested against the experimental disease produced with 6
different strains of freshly isolated H. pertussis.
It is evident from data offered in the table that the number of
organisms required to kill fifty per cent of the drug-treated mice was
from 1.5 to 8 times that required to kill a like percentage of the
controls. While there were generally fewer ofthe surviving treated
mice showing positive lungcultures, the difference was not significant
except in the case of strains Fi and Ba. In Hornibrook's experiment6
cultures showing fewer than 100 colonies per plate were interpreted
as negative, while we have considered the presence of even a single
colony as a positive culture. Had we employed less severe criteria
it is probable that our results would have more nearly agreed with
those of Hornibrook. The results, however, indicate that under
the conditions of the experiment sulfadiazine alone exerts a definite,
*The immune rabbit globulin (anti-pertussis serum) was kindly supplied by
Dr. W. E. Bunney, E. R. Squibb and Co.; the pertussis antitoxin was obtained
through the courtesy of Dr. A. L. Joyner, The Lederle Laboratories, Pearl River,
N. Y.
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though not impressive, favorable effect upon experimental pertussis
in the mouse.
Since it is known that an antibacterial serum11 is definitely pro-
tective in experimental murine pertussis, it was decided to test the
effect of sulfadiazine in combination with these biological products
and to compare the results with those obtained by treatment with
either the drug alone or with serum alone. The results of two such
experiments are presented in Table 2.
From the data of the first experiment (Table 2) it is evident
that the number of organisms (111 million) necessary to kill fifty
per cent of the mice treated with sulfadiazine was almost 22 times
that (5 million) required to kill the controls. The M.L.D. for the
mice treated 24 hours after infection with immune rabbit globulin
was 109 million organisms, while that of the group receiving com-
bined drug and serum treatment was 62 million organisms. In this
experiment, therefore, the protective power of either the drug alone,
or of the serumalone was greater than that of the conmbination of the
two agents. In the second experiment, the combined therapy gave
a slightly better result than did serum alone and a definitely better
result than did sulfadiazine alone.
Intheeffect onthe disappearance of theorganisms fromthe lungs
of surviving mice the difference between the serum-treated or the
drug-treated and the combined serum- and drug-treated group was
distinctly in favor ofthe combined therapy. In experiment 1 (Table
2) 56 per cent of the sulfadiazine-treated group and 55 per cent of
the serum-treated group yielded positive cultures, while only 8
per cent of the combined-treated group were positive. This differ-
ence in favor of combined therapy is statistically significant in both
experiments 1 and 2. This clearing effect was even more marked
than is apparent from the protocols, because the relative number of
colonies is not shown. In many instances, only a fewcolonies (some-
times only a single one) were observed on cultures of the lungs of
the mice receiving the combined type of treatment. These mice, of
course, were tabulated in theprotocols as having positive cultures.
The data given in Table 3 (experiment 1) show that a com-
bination of sulfadiazine and pertussis antitoxin was not only more
protective than either drug or antitoxin alone, but also that only
the combined therapy was effective in causing the disappearance
of the organisms from the lungs of surviving mice.
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In experiment 2 this was also true, but less significant, because
both the drug and the antitoxin alone were equally as effective.
In general, the data included in Table 2 show that sulfadiazine
and the immune globulin alone were each effective once, but failed
once, to produce clearing of the organisms from the lungs, while in
combination they were effective in both experiments. A similar
conclusion may be drawn from the data of Table 3 concerning sulfa-
diazine and the antitoxin.
The practical application of the combined therapy to the treat-
ment of early cases of pertussis in infants is obvious. The difficulty
encountered in accurately assessing the therapeutic value of any
agent in whooping cough is equally obvious. One of the criteria
which can be controlled, however, is the dearing of the organisms
from the naso-pharynx as tested by repeated nasopharyngeal cul-
tures.2 The results of such a study, now in progress in our clinic,
indicate that a rapid disappearance of H. pertussis from the upper
respiratory tract occurs when sulfadiazine and the antibacterial
serum (immune globulin) are administered to infants during the
catarrhal period of the disease.
Sumnary
Sulfadiazine, an immune rabbit globulin (anti-bacterial serum),
and an antitoxin were each found to protect mice against
experimental murine pertussis when administered 24 hours after
infection. Each of these therapeutic agents brought about the dis-
appearance of the organisms from the lungs of surviving mice, but
thiseffect was not always reproducible.
When a combined form of therapy, consisting in either sulfa-
diazine with immune rabbit globulin or sulfadiazine with antitoxin,
was used there was effective clearance of the organisms from the
lungs and protection ofthe mice from death.
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